{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-279483","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2026-06-23T20:19:56+00:00","discovered_at":"2026-06-23T20:21:00.304866+00:00","generated_at":"2026-06-23T20:21:07.145282+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Olema shareholders elect directors, approve executive compensation, ratify auditor at 2026 annual meeting","bullets":["Four Class III directors elected: Bohen (67.5M for), Garland (66.2M), Larson (50.4M), Rappaport (67.3M).","Advisory vote on executive compensation approved: 68.0M for, 654K against, 15.9K abstain.","Ernst & Young ratified as independent auditor for FY2026: 75.8M for, 272K against, 52.5K abstain.","Broker non-votes of 7.5M on director and compensation proposals; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-279483","json":"https://secwatch.observer/filing/0001193125-26-279483.json","markdown":"https://secwatch.observer/filing/0001193125-26-279483.md","text":"https://secwatch.observer/filing/0001193125-26-279483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526279483/0001193125-26-279483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526279483/olma-20260617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T20:21:07.145282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}